Patient stratification and targeted drug therapy - T2 asthma and beyond

P. Nair (Hamilton (ON), Canada)

Source: International Congress 2018 – PG17 Asthma phenotyping
Session: PG17 Asthma phenotyping
Session type: Postgraduate Course
Number: 194
Disease area: Airway diseases

WebcastSlide presentation

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
P. Nair (Hamilton (ON), Canada). Patient stratification and targeted drug therapy - T2 asthma and beyond. International Congress 2018 – PG17 Asthma phenotyping

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
The patient’s role in the choice of new inhaler devices and dosing regimens for asthma and COPD: A preference study
Source: International Congress 2016 – Kaleidoscope of respiratory nursing
Year: 2016


Combination therapy versus separate therapy in real-life primary care asthma patients
Source: International Congress 2015 – Management of asthma and other respiratory diseases in primary care
Year: 2015


Development and evaluation of an educational intervention targeted at optimising adherence with measures to prevent asthma in children with a familial allergic disposition (FOCUS-project)
Source: Eur Respir J 2002; 20: Suppl. 38, 329s
Year: 2002

Symptom pattern and treatment for people non-compliant with asthma medication
Source: Annual Congress 2005 - Allergic rhinitis and asthma in primary care
Year: 2005


The parameters that may affect inhalation therapy success in elderly COPD and asthma patients
Source: International Congress 2015 – Co-existing diseases and asthma
Year: 2015


The effectiveness of patient education to improve adherence to the asthma treatment
Source: International Congress 2016 – Clinical characteristics of asthma
Year: 2016


Application of biomarkers and patient characteristics to personalize asthma treatment for children
Source: International Congress 2016 – Deep phenotyping to improve treatment outcomes in paediatric asthma
Year: 2016


Patient baseline variables predict future asthma control status and risk of exacerbations
Source: Annual Congress 2010 - Management of airway disease
Year: 2010

Prescribing patterns for UK patients commencing first maintenance therapy for COPD
Source: International Congress 2014 – COPD markers
Year: 2014


Difficult-to-treat asthma : a multidimensional approach before considering targeted therapy
Source: International Congress 2019 – Asthma: outcomes of clinical trials and cohorts
Year: 2019

Clinical, functional and laboratory assessment of treatment efficacy in COPD patients
Source: International Congress 2014 – Predictors
Year: 2014


Asthma-associated factors - Potential predictive markers for patients stratification, personalized treatments and prevention
Source: International Congress 2016 – Asthma points to ponder
Year: 2016


Influence of patient baseline characteristics and concomitant medication on outcomes in long-term trials of COPD: Analysis of the UPLIFT® trial
Source: Annual Congress 2013 –Clinical trials of LAMAs, LABAs, MABAs and theophylline for asthma and COPD
Year: 2013

Managing asthma patients: which outcomes matter?
Source: Eur Respir Rev 2008; 17: 53-61
Year: 2008



Childhood asthma - symptom awareness and therapeutic options study
Source: Eur Respir J 2001; 18: Suppl. 33, 145s
Year: 2001

Looking back to go forward: adherence to inhaled therapy before biologic therapy in severe asthma
Source: Eur Respir J, 55 (5) 2000954; 10.1183/13993003.00954-2020
Year: 2020



ADEPT, airway disease endotyping for personalized treatment: Interim analysis of asthma patients
Source: Annual Congress 2013 –Novel drugs and biomarkers in respiratory medicine
Year: 2013

Additive effect of targeted lung denervation plus drug in patients with COPD
Source: International Congress 2015 – Novel treatments for cough, asthma, COPD and bronchiectasis
Year: 2015

Adherence to asthma medication and preferences for once-daily treatment: Importance of treatment intrusiveness and patient beliefs
Source: International Congress 2016 – Notable abstracts on clinical problems related to asthma
Year: 2016